アルファ放射体の世界市場2021-2027:放射性核種タイプ別(アスタチン(At-211)、ラジウム(Ra-223)、鉛(Pb-212)、ビスマス(Bi-212)、アクチニウム(Ac-225)、その他)、医療用途別、地域別

【英語タイトル】Global Alpha Emitter Market size study by Type of Radionuclide (Astatine (At-211), Radium (Ra-223), Lead (Pb-212), Bismuth (Bi-212), Actinium (Ac-225), and Other Type of Radionuclides), Medical Application (Prostate Cancer, Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, and Other Medical Applications), Regional Forecasts 2021-2027

Bizwit Research & Consultingが出版した調査資料(BZW21OC274)・商品コード:BZW21OC274
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2021年9月15日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2020年におよそXX億ドルであったアルファ放射体の世界市場規模が、2021年から2027年の間に36.7%以上の健全な成長率で成長すると予測しています。本調査資料では、世界のアルファ放射体市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、放射性核種タイプ別(アスタチン(At-211)、ラジウム(Ra-223)、アクチニウム(Ac-225)、鉛(Pb-212)、ビスマス(Bi-212))分析、医療用途別(前立腺がん、骨転移、卵巣がん、膵臓がん、内分泌腫瘍)分析、地域別分析、競争状況、調査プロセスなどの項目を掲載しております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・アルファ放射体の世界市場規模:放射性核種タイプ別(アスタチン(At-211)、ラジウム(Ra-223)、アクチニウム(Ac-225)、鉛(Pb-212)、ビスマス(Bi-212))
・アルファ放射体の世界市場規模:医療用途別(前立腺がん、骨転移、卵巣がん、膵臓がん、内分泌腫瘍)
・アルファ放射体の世界市場規模:地域別
・競争状況
・調査プロセス

Global Alpha Emitter Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 36.7% over the forecast period 2021-2027. Alpha emitters are useful in the therapy of cancer. The properties of alpha emitters have resulted in significant differences between this discipline and other nuclear medicine specialties. Alpha particles have been widely used in medical studies due to their limited range and high LET (deposit energy per unit length of route). Ovarian cancer, pancreatic cancer, lymphoma, and melanoma are among of the malignancies that are treated using alpha emitters. The treatment method employs a variety of radionuclides, including radium, lead, and bismuth. Increased awareness of the potential advantages of targeted alpha treatment, as well as the rising number of patients with cardiac and cancer diseases, are driving market growth. Furthermore, the growth is due to an increase in the number of new diagnostic cases. According to the American Cancer Society, around 22,240 women are projected to be diagnosed with ovarian cancer in 2018, with approximately 14,070 women dying from the disease. In addition, At-211-MX35 F (ab′) showed significant effectiveness in a recent Phase I clinical trial, with therapeutic doses reaching their goals in patients with ovarian cancer. However, stringent regulatory framework and reimbursement issues may impede market growth over the forecast period of 2021-2027.

North America currently dominates the alpha emitter market, and it is projected to remain so for a few more years. The increase in cardiac and neurological chronic illnesses, which is the primary driving reason for market growth in the region. For example, 223RaCl2 (Xofigo) is the first alpha emitting radioisotope to be approved for palliative treatment of prostate cancer bone metastases by indirect physiological targeting in the United States.

Major market player included in this report are:
Alpha Tau Medical Ltd
Actinium Pharmaceuticals Inc.
IBA Radiopharma Solutions
Telix Pharmaceuticals Ltd
Fusion Pharmaceuticals
RadioMedix Inc.
Bayer AG.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Radionuclide:
Astatine (At-211)
Radium (Ra-223)
Actinium (Ac-225)
Lead (Pb-212)
Bismuth (Bi-212)
Other Type of Radionuclides

By Medical Application:
Prostate Cancer
Bone Metastasis
Ovarian Cancer
Pancreatic Cancer
Endocrine Tumors
Other Medical Applications

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Alpha Emitter Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Alpha Emitter Market, by Region, 2019-2027 (USD Billion)
1.2.2. Alpha Emitter Market, by Type of Radionuclide, 2019-2027 (USD Billion)
1.2.3. Alpha Emitter Market, by Medical Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Alpha Emitter Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Alpha Emitter Market Dynamics
3.1. Alpha Emitter Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing number of patients with cardiac and cancer ailments
3.1.1.2. Increased awareness about the potential benefits of targeted alpha therapy
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory framework and reimbursement issues
3.1.3. Market Opportunities
3.1.3.1. Product launches
Chapter 4. Global Alpha Emitter Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Alpha Emitter Market, by Type of Radionuclide
5.1. Market Snapshot
5.2. Global Alpha Emitter Market by Type of Radionuclide, Performance – Potential Analysis
5.3. Global Alpha Emitter Market Estimates & Forecasts by Type of Radionuclide 2018-2027 (USD Billion)
5.4. Alpha Emitter Market , Sub Segment Analysis
5.4.1. Astatine (At-211)
5.4.2. Radium (Ra-223)
5.4.3. Actinium (Ac-225)
5.4.4. Lead (Pb-212)
5.4.5. Bismuth (Bi-212)
5.4.6. Other Type of Radionuclides
Chapter 6. Global Alpha Emitter Market, by Medical Application
6.1. Market Snapshot
6.2. Global Alpha Emitter Market by Medical application, Performance – Potential Analysis
6.3. Global Alpha Emitter Market Estimates & Forecasts by medical Application 2018-2027 (USD Billion)
6.4. Alpha Emitter Market , Sub Segment Analysis
6.4.1. Prostate Cancer
6.4.2. Bone Metastasis
6.4.3. Ovarian Cancer
6.4.4. Pancreatic Cancer
6.4.5. Endocrine Tumors
6.4.6. Other Medical Applications
Chapter 7. Global Alpha Emitter Market, Regional Analysis
7.1. Alpha Emitter Market , Regional Market Snapshot
7.2. North America Alpha Emitter Market
7.2.1. U.S. Alpha Emitter Market
7.2.1.1. Type of Radionuclide breakdown estimates & forecasts, 2018-2027
7.2.1.2. Medical Application breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Alpha Emitter Market
7.3. Europe Alpha Emitter Market Snapshot
7.3.1. U.K. Alpha Emitter Market
7.3.2. Germany Alpha Emitter Market
7.3.3. France Alpha Emitter Market
7.3.4. Spain Alpha Emitter Market
7.3.5. Italy Alpha Emitter Market
7.3.6. Rest of Europe Alpha Emitter Market
7.4. Asia-Pacific Alpha Emitter Market Snapshot
7.4.1. China Alpha Emitter Market
7.4.2. India Alpha Emitter Market
7.4.3. Japan Alpha Emitter Market
7.4.4. Australia Alpha Emitter Market
7.4.5. South Korea Alpha Emitter Market
7.4.6. Rest of Asia Pacific Alpha Emitter Market
7.5. Latin America Alpha Emitter Market Snapshot
7.5.1. Brazil Alpha Emitter Market
7.5.2. Mexico Alpha Emitter Market
7.6. Rest of The World Alpha Emitter Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Alpha Tau Medical Ltd
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Actinium Pharmaceutical Inc.
8.2.3. IBA Radiopharma Solutions
8.2.4. Telix Pharmaceuticals Ltd
8.2.5. Fusion Pharmaceuticals
8.2.6. RadioMedix Inc.
8.2.7. Bayer AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Alpha Emitter Market, report scope
TABLE 2. Global Alpha Emitter Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Alpha Emitter Market estimates & forecasts by Type of Radionuclide 2018-2027 (USD Billion)
TABLE 4. Global Alpha Emitter Market estimates & forecasts by medical application 2018-2027 (USD Billion)
TABLE 5. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Alpha Emitter Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Alpha Emitter Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South KoreaAlpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Alpha Emitter Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Alpha Emitter Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of Global Alpha Emitter Market.
TABLE 76. List of primary sources used in the study of Global Alpha Emitter Market.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.

List of figures
FIG 1. Global Alpha Emitter Market, research methodology
FIG 2. Global Alpha Emitter Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Alpha Emitter Market, key trends 2020
FIG 5. Global Alpha Emitter Market, growth prospects 2021-2027
FIG 6. Global Alpha Emitter Market, porters 5 force model
FIG 7. Global Alpha Emitter Market, pest analysis
FIG 8. Global Alpha Emitter Market, value chain analysis
FIG 9. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Alpha Emitter Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Alpha Emitter Market, regional snapshot 2018 & 2027
FIG 18. North America Alpha Emitter Market 2018 & 2027 (USD Billion)
FIG 19. Europe Alpha Emitter Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Alpha Emitter Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Alpha Emitter Market 2018 & 2027 (USD Billion)
FIG 22. Global Alpha Emitter Market, company market share analysis (2020)

★調査レポート[アルファ放射体の世界市場2021-2027:放射性核種タイプ別(アスタチン(At-211)、ラジウム(Ra-223)、鉛(Pb-212)、ビスマス(Bi-212)、アクチニウム(Ac-225)、その他)、医療用途別、地域別] (コード:BZW21OC274)販売に関する免責事項を必ずご確認ください。
★調査レポート[アルファ放射体の世界市場2021-2027:放射性核種タイプ別(アスタチン(At-211)、ラジウム(Ra-223)、鉛(Pb-212)、ビスマス(Bi-212)、アクチニウム(Ac-225)、その他)、医療用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆